Google
Trusted Resources: News & Events
Latest announcements and gatherings
SCDAA Releases Comments on the CDC’s Opioid Guidelines
The Sickle Cell Disease Association of America, Inc., (SCDAA), is pleased to learn that the Centers for Disease Control and Prevention (CDC) is updating the 2016 opioid guidelines. However, the guidelines do not go far enough in providing guidance to providers on how to manage sickle cell disease (SCD) pain. Decades of misinformation, poor guidance, and systemic racism created barriers to receiving adequate care for pain.
SCD is an inherited red blood cell disorder affecting about 100,000 Americans, disproportionately impacting Black and Brown populations. In people with sickle cell disease, red blood cells become crescent-shaped, sticky, and hard. This condition increases the chances of blood clotting, causing pain crises, strokes, and organ damage. People with sickle cell disease also frequently experience a shortage of red blood cells, as these cells die much faster than sickle cell blood cells. Pain can occur throughout the body and can be excruciating, affecting a person’s mental and physical well-being.
+myBinderRelated Content
-
Sickle Cell Disease Program at Children’s HealthThe Sickle Cell Disease Program at Child...
-
Yvonne Carroll, RN, JDYvonne M. Carroll, RN, JD is the Directo...
-
Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in...Importance: In children with sickle cel...
-
Robert I. Liem, MD, MSRobert I. Liem is Associate Professor of...
-
Dexmedetomidine as an adjuvant to analgesic strategy during vaso-occlusive episodes in adolescents with sickle cell ...Sickle cell disease (SCD)-patients exper...
-
Sickle Cell Patients Endure Discrimination, Poor Care And Shortened LivesFor more than a year, NeDina Brocks-Capl...
-
Sickle Cell Treatment ‘Life-Changing’ for Brockton BrothersEmmanuel “Manny” Johnson, 21, of Bro...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.